Retha Blevins
Family · Marion, VANPI 1851082465
Payments from drug & device makers
Across 68 payments — averaging $24.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$353
- Otsuka America Pharmaceutical, Inc.$243
- Phathom Pharmaceuticals, Inc.$214
- Novo Nordisk$150
- GSK$110
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$101
- plus $477 from 14 others
What the payments were for
- Food & beverage$1,61098%
- Education$382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $353 |
| Otsuka America Pharmaceutical, Inc. | 13 | $243 |
| Phathom Pharmaceuticals, Inc. | 2 | $214 |
| Novo Nordisk | 7 | $150 |
| GSK | 6 | $110 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $101 |
| Verona Pharma, Inc. | 3 | $93 |
| Lilly USA, LLC | 3 | $65 |
| Shockwave Medical, Inc | 1 | $38 |
| AbbVie | 2 | $36 |
| Lundbeck LLC | 2 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Mylan Specialty L.p. | 1 | $31 |
| Astellas Pharma US Inc | 2 | $31 |
| Boston Scientific | 1 | $27 |
| Abbott | 1 | $21 |
| Exact Sciences | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,647 in reported general payments places this provider in the 80th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 74 | $78,087 |
| MounjaroTirzepatide | 52 | $55,693 |
| OzempicSemaglutide | 31 | $38,238 |
| EliquisApixaban | 40 | $34,017 |
| JanuviaSitagliptin Phosphate | 37 | $31,892 |
| JardianceEmpagliflozin | 25 | $21,863 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $16,964 |
| FarxigaDapagliflozin Propanediol | 14 | $9,783 |
| BrilintaTicagrelor | 12 | $6,805 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $5,179 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 125 | $3,035 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $2,874 |
| LantusInsulin Glargine,hum.Rec.Anlog | 11 | $2,394 |
| Omeprazole | 143 | $2,160 |
| Esomeprazole Magnesium | 42 | $2,122 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $65 | $133,780126 claims |
| Novo NordiskOzempic | $150 | $38,23831 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $353 | $21,76748 claims |
| GSKTrelegy Ellipta | $110 | $16,96424 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,332 family providers in Virginia.
Other family in Marion
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.